Form 4: Chemours Exec's Routine Tax Withholding
Insider Transaction Report
A Chemours Company executive reported the automatic withholding of shares to cover tax obligations related to vested equity awards.
Summary
- Kristine M. Wellman, SVP, GC & Corp. Secretary of The Chemours Company (CC), reported a transaction on August 1, 2025.
- 383 shares of Common Stock were disposed of at a price of $11.5 per share.
- This disposition was an automatic withholding of shares to satisfy tax obligations on vesting restricted stock units and dividend equivalent units.
- No shares were sold in an open market transaction.
- Following this transaction, Kristine M. Wellman beneficially owns 52,860.8009 shares, including directly owned shares, restricted stock units, and dividend equivalent units.
- The transaction is exempt from Section 16(b) pursuant to Rule 16b-3.
Sentiment
Score: 5
Explanation: The filing reports a routine, non-discretionary transaction (tax withholding) related to executive compensation, which is neutral in terms of company performance or outlook.
Positives
- The transaction was an automatic withholding for tax purposes, not an open market sale by the executive, indicating no discretionary selling.
- The transaction is exempt from Section 16(b) under Rule 16b-3, confirming compliance with regulations.
Future Outlook
The filing does not provide forward-looking statements or guidance beyond the reported transaction.
Management Comments
- The filing includes a signature by Eric Stein, Attorney-in-Fact, on behalf of Kristine M. Wellman, and a Power of Attorney document outlining the authority granted to Eric Stein to execute SEC filings.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, specifically related to executive compensation and tax obligations. It does not provide broader industry context or trends.
Comparison to Industry Standards
- This is a standard Form 4 filing for tax withholding on vested equity, a common practice across publicly traded companies. There are no specific comparable companies, projects, or results mentioned in the filing to assess against global benchmarks.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Kristine M. Wellman granted Eric Stein power of attorney to execute Forms 3, 4, and 5 on her behalf for SEC compliance. | 08/04/2025 | Streamlines the process for executive SEC filings, ensuring timely compliance with Section 16(a) of the Securities Exchange Act of 1934. |
Stakeholder Impact
- The transaction is a routine tax withholding event for an executive's equity compensation and has no material direct impact on shareholders, employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 08/01/2025 | Date of transaction for disposition of shares to satisfy tax obligations. |
| 08/04/2025 | Date Power of Attorney was executed by Kristine M. Wellman. |
| 08/05/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Chemours Company, CC, SEC Form 4, Insider Transaction, Stock Ownership, Tax Withholding, Restricted Stock Units, Dividend Equivalent Units, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.